- Home
- GLTO vs TC Comparison
GLTO vs TC Comparison
Compare GLTO & TC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLTO
- TC
- Stock Information
- Founded
- GLTO 2011
- TC 2010
- Country
- GLTO Denmark
- TC China
- Employees
- GLTO N/A
- TC N/A
- Industry
- GLTO Biotechnology: Pharmaceutical Preparations
- TC Business Services
- Sector
- GLTO Health Care
- TC Consumer Discretionary
- Exchange
- GLTO Nasdaq
- TC Nasdaq
- Market Cap
- GLTO 23.7M
- TC 25.0M
- IPO Year
- GLTO 2020
- TC 2018
- Fundamental
- Price
- GLTO $5.72
- TC $18.56
- Analyst Decision
- GLTO
- TC
- Analyst Count
- GLTO 0
- TC 0
- Target Price
- GLTO N/A
- TC N/A
- AVG Volume (30 Days)
- GLTO 767.1K
- TC 14.5K
- Earning Date
- GLTO 11-04-2025
- TC 12-16-2025
- Dividend Yield
- GLTO N/A
- TC N/A
- EPS Growth
- GLTO N/A
- TC N/A
- EPS
- GLTO N/A
- TC N/A
- Revenue
- GLTO N/A
- TC $5,115,721.00
- Revenue This Year
- GLTO N/A
- TC N/A
- Revenue Next Year
- GLTO N/A
- TC N/A
- P/E Ratio
- GLTO N/A
- TC N/A
- Revenue Growth
- GLTO N/A
- TC N/A
- 52 Week Low
- GLTO $2.01
- TC $9.20
- 52 Week High
- GLTO $31.70
- TC $39.00
- Technical
- Relative Strength Index (RSI)
- GLTO 42.06
- TC 70.64
- Support Level
- GLTO $7.02
- TC $16.50
- Resistance Level
- GLTO $7.64
- TC $18.00
- Average True Range (ATR)
- GLTO 0.58
- TC 1.27
- MACD
- GLTO -0.55
- TC 0.11
- Stochastic Oscillator
- GLTO 0.25
- TC 74.60
About GLTO Galecto Inc.
Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of cancer and liver diseases. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis.
About TC TuanChe Limited
Token Cat Ltd is an omnichannel automotive marketplace in China. The company operates in one segment, providing auto shows, special promotion event services, virtual dealerships, online marketing services, and more. It organizes auto shows to facilitate transactions between consumers and auto dealers, which include auto dealers, automakers, and automotive service providers. It offers services through its online platform and offline events.